These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26153214)

  • 1. The Effects of Medicago Sativa and Allium Porrum on Iron Overload in Rats.
    Mirzaei A; Delaviz H; Mirzaei M; Tolooei M
    Glob J Health Sci; 2015 Apr; 7(7 Spec No):137-42. PubMed ID: 26153214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Mangiferin in the Prevention of Experimentally Induced Iron Overload in an Animal Model.
    Estuningtyas A; Setiabudy R; Wahidiyat PA; Freisleben HJ
    Drug Res (Stuttg); 2019 Apr; 69(4):234-240. PubMed ID: 30189460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of different iron chelators in Egyptian children with Beta Thalassemia with iron overload.
    Hagag AA; Hamam MA; Taha OA; Hazaa SM
    Infect Disord Drug Targets; 2015; 15(2):98-105. PubMed ID: 26205801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deferasirox for managing iron overload in people with thalassaemia.
    Bollig C; Schell LK; Rücker G; Allert R; Motschall E; Niemeyer CM; Bassler D; Meerpohl JJ
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD007476. PubMed ID: 28809446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation into Iron Chelating and Antioxidant Potential of Melilotus officinalis in Iron Dextran Induced Iron Overloaded Sprague Dawley Rat Model.
    Sheikh NA; Desai TR; Tirgar PR
    Drug Res (Stuttg); 2016 Dec; 66(12):618-627. PubMed ID: 27626608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The iron chelating activity of Gundelia tournefortii in iron overloaded experimental rats.
    Mansi K; Tabaza Y; Aburjai T
    J Ethnopharmacol; 2020 Dec; 263():113114. PubMed ID: 32736049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine.
    Moayedi B; Gharagozloo M; Esmaeil N; Maracy MR; Hoorfar H; Jalaeikar M
    Eur J Haematol; 2013 Mar; 90(3):202-9. PubMed ID: 23278124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ellagic acid isolated from Clerodendrum viscosum leaves ameliorates iron-overload induced hepatotoxicity in Swiss albino mice through inhibition of oxidative stress and the apoptotic pathway.
    Shendge AK; Basu T; Panja S; Chaudhuri D; Mandal N
    Biomed Pharmacother; 2018 Oct; 106():454-465. PubMed ID: 29990833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1).
    Kontoghiorghes GJ; Pattichi K; Hadjigavriel M; Kolnagou A
    Transfus Sci; 2000 Dec; 23(3):211-23. PubMed ID: 11099897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Fisher SA; Brunskill SJ; Doree C; Gooding S; Chowdhury O; Roberts DJ
    Cochrane Database Syst Rev; 2013 Aug; (8):CD004450. PubMed ID: 23963793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
    Kolnagou A; Yazman D; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):312-22. PubMed ID: 19814677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of iron overload-induced liver toxicity by a potent antioxidant and iron chelator, Emblica officinalis Gaertn.
    Sarkar R; Hazra B; Mandal N
    Toxicol Ind Health; 2015 Jul; 31(7):656-69. PubMed ID: 23524878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the protective effects of Katha (Heartwood Extract of Acacia catechu) in liver damage induced by iron overload.
    Hazra B; Sarkar R; Ghate NB; Chaudhuri D; Mandal N
    J Environ Pathol Toxicol Oncol; 2013; 32(3):229-40. PubMed ID: 24266409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term comparative studies in thalassemia patients treated with deferoxamine or a deferoxamine/deferiprone combination. Identification of effective chelation therapy protocols.
    Kolnagou A; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2008; 32(1-2):41-7. PubMed ID: 18274982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron chelation suppresses ferritin upregulation and attenuates vascular dysfunction in the aorta of angiotensin II-infused rats.
    Ishizaka N; Saito K; Mori I; Matsuzaki G; Ohno M; Nagai R
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2282-8. PubMed ID: 16100038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Deferasirox (Exjade®) in Modulation of Iron Overload in Patients with β-Thalassemia Intermedia.
    Karimi M; Arandi N; Haghpanah S; Ansari S; Azarkeyvan A; Bordbar M; Safaei S
    Hemoglobin; 2015; 39(5):327-9. PubMed ID: 26114738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the prophylactic effect of silymarin and deferoxamine on iron overload-induced hepatotoxicity in rat.
    Najafzadeh H; Jalali MR; Morovvati H; Taravati F
    J Med Toxicol; 2010 Mar; 6(1):22-6. PubMed ID: 20182837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new era in iron chelation therapy: the design of optimal, individually adjusted iron chelation therapies for the complete removal of iron overload in thalassemia and other chronically transfused patients.
    Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):332-8. PubMed ID: 19814679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Efficacy and Safety of Oral Iron Chelators and their Novel Combination in Children with Thalassemia.
    Gomber S; Jain P; Sharma S; Narang M
    Indian Pediatr; 2016 Mar; 53(3):207-10. PubMed ID: 27029681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.